| name | icsm-tt-monotherapy-mild-ed |
| description | Reserve testosterone monotherapy for men with mild erectile dysfunction and an absolute demonstration of hypogonadism; otherwise combine testosterone therapy with a PDE5 inhibitor. Triggered when a clinician managing erectile dysfunction asks whether testosterone alone is sufficient or a PDE5 inhibitor should be added. |
Reserve testosterone monotherapy for mild erectile dysfunction with proven hypogonadism
STEP 1 — Gather Information
- Confirm erectile dysfunction and assess severity (mild vs moderate/severe) using IIEF-5 or clinical judgment.
- Document symptoms suggestive of hypogonadism (low libido, decreased morning erections, fatigue).
- Obtain two morning total testosterone (tT) measurements (fasting, 07:00–11:00 h) using a reliable assay; absolute demonstration of hypogonadism = tT <12 nmol/L on both occasions.
- Note any prior use of PDE5 inhibitors and response.
STEP 2 — Rule In / Rule Out
Is the erectile dysfunction mild?
- No → Testosterone monotherapy not appropriate; proceed to combination therapy or PDE5 inhibitor alone based on hypogonadism status.
- Yes → Continue to assess hypogonadism.
STEP 3 — Classify or Stratify
Is there an absolute demonstration of hypogonadism (tT <12 nmol/L on two morning samples)?
- Yes → Candidate for testosterone monotherapy.
- No → Testosterone monotherapy not indicated; consider combining testosterone therapy with a PDE5 inhibitor.
STEP 4 — Decide
- If mild ED and absolute hypogonadism → Initiate testosterone monotherapy (e.g., transdermal gel targeting mid-normal tT).
- Otherwise → Prescribe testosterone therapy combined with a PDE5 inhibitor (or PDE5 inhibitor alone if eugonadal) and reassess erectile function in 3 months.
Clinical Guardrails / Mimics / Pitfalls
- Do not use testosterone monotherapy in men without two‑step approach: never start monotherapy without confirming low tT on two separate occasions.
- Avoid monotherapy in moderate or severe ED; efficacy is limited and combination is preferred.
- Monitor hematocrit, PSA, and symptoms; withdraw if hematocrit >54% or adverse events occur.
- Do not rely on monotherapy to treat depression, obesity, or metabolic disease alone.
Concrete Clinical Example
A 58‑year‑old man reports mild erections (IIEF‑5 16) and low libido. Morning tT is 10 nmol/L on two separate visits. He asks if testosterone alone will help. Since ED is mild and hypogonadism is proven, start testosterone gel 5 mg daily. At 3‑month follow‑up, IIEF‑5 improves to 20; if further improvement desired, add sildenafil 50 mg PRN.
Source: International Consultation on Sexual Medicine (ICSM) 2024, Box2 Recommendation 8, 2025, https://doi.org/10.1093/sxmrev/qeaf036
